Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Identify Molecular Mechanisms of Clinical Resistance to Standard First-line Therapy in Patients With Metastatic Colorectal Cancer

NCT00984048 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT00984048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00984048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Identify Molecular Mechanisms of Clinical Resistance to Standard First-line Therapy in Patients With Metastatic Colorectal Cancer
Lead sponsor
Jewish General Hospital
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2019
Enrollment
160 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer